TECON BIOLOGY Co.LTD (SHE:002100)
China flag China · Delayed Price · Currency is CNY
7.70
-0.19 (-2.41%)
Oct 28, 2026, 2:05 PM CST

TECON BIOLOGY Co.LTD Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-797.14210.63605.05-1,363280.78-702.79
Depreciation & Amortization
823.43826.07888.53802.92713.19704.95
Other Amortization
23.7821.1413.0511.1112.4939.34
Loss (Gain) From Sale of Assets
-0.59-0.59-4.5-3.9-0.2336.72
Asset Writedown & Restructuring Costs
5.725.7241.5843.737.82458.49
Loss (Gain) From Sale of Investments
-34.64-34.641.87-3.46-17.81-30.92
Other Operating Activities
-649.87291.27179.93583.11264.25213.53
Change in Accounts Receivable
148.49148.49-605.88855.47-528.52759.92
Change in Inventory
-969.27-969.27367.9861.26-548.38158.82
Change in Accounts Payable
-236.86-236.869.48-65.2178.85-98.63
Change in Other Net Operating Assets
131.54131.54-307.6653.250.36-
Operating Cash Flow
-1,568380.861,1621,752327.991,533
Operating Cash Flow Growth
--67.22%-33.68%434.11%-78.60%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-419.41-378.95-626.46-1,001-1,430-1,752
Sale of Property, Plant & Equipment
3.744.156.350.8927.893.35
Cash Acquisitions
-562.41---359.19-31.55-37.98
Divestitures
-----14.1
Investment in Securities
-940.55-913.55-130580.53-656.24-6.63
Other Investing Activities
16.330.90.094.1117.584.3
Investing Cash Flow
-1,902-1,287-750.02-775-2,072-1,775

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-5,3646,8204,9154,9825,871
Total Debt Issued
7,7975,3646,8204,9154,9825,871
Long-Term Debt Repaid
--5,558-6,786-5,882-4,740-5,611
Lease Payments
-149.68-149.68-84.34---
Total Debt Repaid
-5,675-5,558-6,786-5,882-4,740-5,611
Net Debt Issued (Repaid)
2,122-193.9433.7-966.46242.3260.23
Issuance of Common Stock
--42.35--2,045
Common Dividends Paid
--442.61-173.32-520.34-260.85-701.74
Other Financing Activities
-157.420.46-33.6-18.391,652-
Financing Cash Flow
1,964-636.1-130.87-1,5051,6341,604

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.05-0.05----
Net Cash Flow
-1,506-1,543280.98-528.37-110.821,361

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-1,9871.91535.4750.48-1,102-219.37
Free Cash Flow Growth
--99.64%-28.66%---
Free Cash Flow Margin
-12.28%0.01%3.12%3.94%-6.49%-1.40%
Free Cash Flow Per Share
-1.430.000.390.56-0.82-0.20
Levered Free Cash Flow
443.58-202.32156.981,155-1,785-89.81
Unlevered Free Cash Flow
537.06-102.32268.811,308-1,63039
Free Cash Flow After Leases
-2,137-147.77451.06750.48-1,102-219.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
39.74159.47191.38110.88214.53121.89
Change in Working Capital
-938.75-938.75-563.641,682-962.5813.64